Corium Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Citeline's Biomedtracker. Lotus Licenses Corium’s Alzh

Emalex Biosciences Inc. significantly expanded on its previous capacity to fund the upcoming Phase III clinical trial of ecopipam in Tourette’s syndrome with a $250m series D financing barely a year

"Tulip mania" was the first documented major economic bubble and also one of the most famous market crashes. It happened during the seventeenth century in Holland when speculators sent prices of tulip

Orphan drugs continue to dominate the novel agents clearing the FDA Center for Drug Evaluation and Research in 2022. The approval of Marinus Pharmaceuticals, Inc. ’s Ztalmy marked the fourth consecut